A commercially available disk diffusion procedure was used in a large-scale study to evaluate the susceptibility of a wide range of Candida isolates to polyenes and azoles. With almost all isolates of C. glabrata resistant colonies were present within the inhibition zones for the azole compounds fluconazole, ketoconazole and miconazole, and less frequently for isoconazole, econazole and clotrimazole. Ten randomly selected isolates were cloned by limiting dilution and the susceptibility of the resulting strains to polyenes and azoles was determined. All strains presented a similar susceptibility pattern with sensitivity to polyenes and the presence of resistant colonies for all azole compounds except tioconazole. For each strain and each antifungal agent, one of these resistant colonies was subcultured and studied for antifungal susceptibility. All these colonies showed similar properties regardless of which antifungal agent allowed their selection, with increased sensitivity to polyenes and cross-resistance to the azole compounds except tioconazole. Similar results were obtained on Shadomy's modified medium and on synthetic medium. Likewise, determination of MICs by the Etest method confirmed the resistance to fluconazole. Comparative growth studies revealed a respiratory deficiency in the mutants caused by mitochondria1 DNA (mtDNA) deletions. In addition, 'petite' mutants were obtained from a wild-type strain by exposure to ethidium bromide, and these respiratory mutants were shown to be resistant to azoles. These results demonstrate the relationship between mtDNA deficiency and resistance to azoles, and provide an interesting model to study the mechanisms of action of these antifungal agents.
Introduction
During the past two decades, the development of antibiotic treatments, the widespread use of immunosuppressive therapy and the emergence of AIDS have led to a marked increase in the prevalence of candidosis. Moreover, as a consequence of the resulting extensive use of antifungal agents, a shiR in the nature of the infecting organisms has been reported [ 1, 21 . Candida albicans remains the most frequent causative agent, but infections due to other yeast species initially considered as non-pathogens, such as C. krusei and C. glabrata, are reported increasingly. C. glabrata, the second commonest species in vaginal candidosis and candiduria, has become the second most common species in candidaemia in some centres, its frequency in this situation increasing from 2 % in 1987 to 26% in 1992 [3] .
To treat these infections, several potent antifungal imidazoles and triazoles have been developed. Because of its pharmacokinetic properties, efficiency and low toxicity, the use of fluconazole in the prophylaxis and therapy of candidosis in organ or bone marrow transplant recipients, patients undergoing chemotherapy and AIDS patients has increased rapidly [4] . Since 1990, fluconazole-resistant isolates of C. albicans have been reported increasingly, particularly in AIDS patients [l] . It is now established that the prolonged use of ketoconazole and fluconazole may give rise to the emergence of C. glabrata infections [l] .
The need for in-vitro susceptibility testing of clinical isolates to fluconazole has become obvious. In-vitro susceptibility testing of yeasts is affected by numerous factors such as inoculum density, media and buffer. A reference macro-broth dilution method (M27-P) has been proposed by the National Committee for Clinical Laboratory Standards [5] . However, this method is time-consuming, expensive and technically difficult to perform. Few commercially available kits suitable for routine clinical practice permit in-vitro susceptibility testing to fluconazole. A disk diffusion procedure (Neosensitabs; Rosco Diagnostica, Taastrup, Denmark) has been shown to be a straight-forward, low-cost and reproducible means of assessing susceptibility of yeasts [6] . The latter procedure was used in this hospital in a large-scale study to evaluate the susceptibility of a wide range of Candida isolates from patients with all types of infections. This method revealed the presence of large resistant colonies within the inhibition zones of azole compounds for almost all isolates of C. glabrata. The significance of these colonies was investigated in a in-vitro study.
Materials and methods

Yeast isolates
The study involved c. 3500 clinical isolates of Candida collected over a 4-year period from patients followed in different units of the teaching university hospital for all types of infections. Yeasts were identified on the basis of germ-tube formation and rice-agar-tween morphology and by their carbohydrate assimilation pattern in ID 32C test strips (bioMkrieux, Marcy-l'Etoile, France). In addition, 10 isolates of C. glabrata cloned by limiting dilution and obtained from unrelated patients sampled before antifungal treatment, were included in the study.
Antifungal susceptibility testing
Disk diffusion method. Susceptibility testing was performed on Casitone (Difco) agar by a commercial agar diffusion method from Rosco Diagnostica (Taastrup, Denmark) [7] . Inoculum in sterile distilled water was prepared from fresh cultures on yeast extract-peptoneglucose (YEPD) agar containing (g/L) yeast extract (9, peptone (lo), glucose (20) , chloramphenicol(1) and agar (20) and standardised by haemocytometer counts. Casitone agar plates containing glucose 2 % and supplemented with chloramphenicol 1 g/L were flooded with 10 ml of the yeast cell suspensions (5 X 1 O5 cells/ml). Excess fluid was removed immediately and plates were dried for 15 min at 37°C. Antifungal NeoSensitabs tablets were then deposited on their surface. Following a pre-incubation period of 30 min at room temperature, plates were incubated for 48 h at 37°C and the diameter of each inhibition zones was measured. The presence of large colonies randomly distributed within the inhibition zones was also noted, and isolates were classified as sensitive, intermediate or resistant according to the manufacturer's recommendations.
For some experiments, susceptibility was also tested on other culture media: Oxoid HR fungal medium (Unipath, Dardilly, France), Shadomy's modified medium (yeast nitrogen base, L-asparagine, glucose, NaH2P04 and K2HP04) and a synthetic mediun from Diagnostics Pasteur (Marnes la Coquette, France).
Student's t test was used for statistical evaluation of the differences in the diameters of the inhibition zones between the mutants and their parents.
Etest procedure. Five colonies from fresh cultures on YEPD agar plates were suspended in saline to achieve a turbidity comparable to a 0.5 McFarland standard. The inoculum was swabbed on to Casitone agar plates which were allowed to dry for 15 min before the Etest strips (AB Biodisk, Solna, Sweden) were applied.
Plates were incubated at 37°C and MICs were read after 48 h as the drug concentration at which the inhibition ellipse intercepted the scale on the antifungal strips. Etest strips of fluconazole, which were stored at -20°C until use, contained a concentration gradient of 0.016-256 mg/L.
Resistant mutants
In the course of antifungal susceptibility testing by the disk diffusion method, one of the large resistant colonies randomly distributed within the inhibition zones was subcultured for each of the 10 strains of C. glabrata and each antifungal agent. These resistant mutants were then cryopreserved and compared to their parent strains by antifungal susceptibility testing, growth study and mitochondria1 DNA (mtDNA) analysis. mtDNA mutants were also induced from C. glabrata LMA 1085.90 by the use of ethidium bromide. The parent strain was cultivated for 12 h at 37°C on YEPD agar plates before a tablet of ethidium bromide (Sigma) was deposited at the centre of the plates. Plates were then incubated for 48 h at 37°C and 10 colonies growing at the margin of the ethidiwn bromide inhibition zone were subcultured and tested for antifungal susceptibility.
Mutation stability
In an attempt to define whether or not a reversion to the parent phenotype was possible in the absence of antifungal agent, the fluconazole-resistant mutants of strains LMA 1085.90 and LMA 5417.94 were subcultured on YEPD agar plates. One hundred bi-weekly passages were performed on YEPD agar and, after every five subcultures, the susceptibility to fluconazole was assessed by disk diffusion on Casitone agar.
Cell growth
Growth of the fluconazole-resistant mutants and of the mtDNA mutants was compared with that of the parent strains on yeast extract-peptone-agar plates containing glucose or glycerol 2%. Growth studies were also performed in YEPD liquid medium inoculated with lo6 blastoconidia/ml and incubated for 24 h at 37°C under aerobic conditions. Growth was evaluated by measuring the absorbance at 450 nm of a 1 in 10 dilution of the fungal suspensions. The mycelial dry weights were also determined by filtration of 5-ml samples of the fungal suspensions through 0.45-pm pore size, 25-mm diameter filters pre-weighed which were then freeze-dried. Results presented correspond to the mean (and SD) of triplicate determinations.
mtDNA extraction and analysis mtDNA was extracted as described previously [8] with slight modifications [9] . Briefly, 100 ml of an overnight cell culture in YEPD liquid medium were pelleted by centrifugation at 500 g for 5 min at room temperature. The pellet was washed twice in sterile distilled water and resuspended in 6ml of a 0.5 M sorbitol, 10 ~M N~~E D T A , 50 m~ Tris buffer, pH 7.6, containing Zymolase 20T (Seikagaku, Tokyo, Japan) 2 mg/ml and 2-mercaptoethanol 0.2 %. After incubation at 37°C for 2 h with gentle shaking, and centrifugation at 1000 g for 10 min to remove nuclei, the supernate was centrifuged at 15 000 g for 10 min to pellet the mitochondria. The resulting pellet was washed five times with the same buffer (without Zymolase and 2-mercaptoethanol). The resulting pellet was lysed by incubation for 30 min at room temperature with 0.7 ml 50 mM Tris buffer, pH 7.8. Nucleic acids were purified (Table 1) . No resistance was observed in the other species included in this study, i.e., C. famata (one isolate), C. glohosa (one), C, humicola (one), C. lipolytica (one), C. pelliculosa (three) and C. rugosa (one), and all the isolates were sensitive to tioconazole. Conversely, resistance to azoles was particularly frequent for C. glabrata: 52% of the isolates tested were classified as resistant to fluconazole and 39% as intermediate (Table 1) . However, only 15 of these isolates, all from patients who had received fluconazole in a 3-month period before the isolation of the yeast, were completely resistant to the drug. The other isolates presented welldefined inhibition zones in which randomly distributed large colonies were observed, some growing directly in contact with the disk. These colonies, which led to classification of the isolate as intermediate or resistant according to their distance from the disk, suggested the presence of resistant mutants.
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Susceptibility pattern of C. glabrata strains
To confirm this hypothesis, 10 isolates of C. glabrata from unrelated patients were cloned by limiting dilution and their susceptibility to polyenes and azoles was studied by the disk diffusion method in Casitone agar; results are presented in Table 2 and Fig. 1 . Large colonies randomly distributed within the inhibition zones, therefore corresponding to resistant mutants, were observed after incubation for 48 h for all the strains tested with isoconazole, clotrimazole, ketoconazole and fluconazole, and for all except one with econazole and miconazole. For each strain and each antihngal agent, the resistant colony nearest the disk was subcultured. Fifty-eight mutants were subcultured and their susceptibility to polyenes and azoles was determined and compared to that of the parent strains. The mutants exhibited the same susceptibility pattern regardless of which antifingal agent allowed their selection, showing a cross-resistance to all the azoles tested except tioconazole. All mutants were completely resistant to isoconazole, clotrimazole, ketoconazole and fluconazole. No inhibition zone was seen with econazole and miconazole for 31 and 35 of the mutants, respectively, whereas the other mutants exhibited a marked decrease in their sensitivity. Conversely, the mutants remained susceptible to tioconazole. Moreover, a significant increase in the susceptibility to polyenes was noted, the diameter of the inhibition zones being statistically greater for the mutants than for the parent strains (t = 6.83; df = 66; p < 0.001 for amphotericin B and t = 4.66; df = 66; p < 0.001 for nystatin).
Influence of the culture medium
Neither mutants nor parent strains grew on HR medium. Furthermore, no resistant colonies were observed from the parent strains on Shadomy's medium or on synthetic medium. However, the mutants previously selected on Casitone agar were completely resistant to econazole, isoconazole, clotrimazole, ketoconazole and fluconazole on these two culture media. Similarly, an increase in the diameter of the inhibition zones was noted with tioconazole and polyenes for the mutants compared with the parent strains.
Determination of fluconazole MICs by the Etest procedure
The Etest procedure performed on Casitone agar 
Stability of the phenotype
The fluconazole-resistant mutants of strains LMA 90.1085 and LMA 94.5417 were subcultured on YEPD agar and resistance to fluconazole was monitored by the disk diffusion method on Casitone agar every five passages. After 100 generations, the mutants remained completely resistant to the drug.
Growth studies
Comparative growth studies on agar medium containing glucose or glycerol 2 % revealed the respiratory deficiency of the fluconazole-resistant mutants. The mutants produced small colonies on glucose-containing agar and did not grown in the presence of glycerol 2 % as the sole carbon source (Table 3) . Conversely, culture of the parent strains yielded large colonies on glucoseagar plates, and growth was only slightly affected by the presence of glycerol.
Growth studies in YEPD liquid medium confirmed the respiratory deficiency. Growth of the mutants was markedly reduced compared with the parent strains; differences in optical densities of 24-h-old cultures between the mutants and their parents ranged from 28% to 49% (Table 3) . Likewise, the mycelial dry weights of the mutants varied from 26% to 37% of those obtained for the parent strains (data not shown).
Analysis of mtDNA
Restriction endonuclease analysis of mtDNA was performed with Eco RV, which has been shown to be the most discriminatory endonuclease for polymorphism analysis in C. glabrata [9] . Three different electrophoretic patterns were observed in parent strains (Fig. 2) . Pattern A (Fig. 2, lines 4 Electrophoresis revealed important deletions of the mtDNA in fluconazole-resistant mutants. No mtDNA was detected after ethidium bromide staining for six of the mutants. For three other mutants, the banding pattern consisted of a unique band with a mol.wt that was always lower than those detected in parent strains (Fig. 2, lines 11, 13 and 15) . Interestingly, one mutant exhibited a very intense band lower than 0.8 kb (Fig.  2 , line ll), suggesting a repeated short sequence (lanes 3, 5, 7, 9, 11,  13, 15, 18, 21, 23 ).
comparable to those observed in 'petite' mutants of Saccharomyces cerevisiae [ lo] . The last mutant, corresponding to strain LMA 970.91, presented two mol.wt fiagments, one equivalent to the 1.7-kb fragment of the parent strain, whereas the other, slightly greater in size, did not correspond to any of the fragments detected in the parent strain (Fig. 2, line  21) . No relationship was observed between the type of mutation (total or partial deletion of the mtDNA) and the banding pattern (A, B or C) of the parent strains.
Study of ethidium bromide-induced mutants
The 10 respiratory mutants induced by ethidium bromide treatment of the wild-type strain LMA 1085.90 were unable to grow on glycerol-agar plates and appeared to be completely devoid of mtDNA after electrophoretic migration (Fig. 3, lines 4-9 ). In addition, antifungal susceptibility studies showed that they were all sensitive to polyenes and tioconazole and completely resistant to the other azole compounds. Conversely, colonies isolated far from the ethidium bromide inhibition zone preserved their ability to grow on glycerol-agar and exhibited an Eco RV electrophoretic pattern (Fig. 3, lines 2 and 3) and a susceptibility pattern identical to that of the parent strain.
Discussion
The agar difision method used in this study showed that, despite the widespread use of antifungal agents, resistance to azoles remains uncommon in most Candida species; < 2 % of C. albicans isolates were intermediate or resistant to fluconazole. The situation was different for C. glabrata, a high proportion of isolates were intermediate or resistant to azoles, particularly the less hydrophobic ketoconazole and fluconazole. With c. 52% of the isolates resistant to fluconazole, these results are in agreement with those of workers who used other experimental procedures, including the reference macro-broth dilution procedure [ 1 1 -131. However, only 15 of the 679 isolates tested were completely resistant to fluconazole. More fiequently, large colonies randomly distributed within the inhibition zones were observed which suggested a mutation leading to azole resistance and posed the question of the mechanisms of this acquired resistance.
The target of azoles is clearly identified as the cytochrome P-450-dependent 14a-sterol demethylase (P-450DM), but the mechanisms of acquired resistance to these antifungal agents are not understood completely. Several resistance mechanisms have been described in C. albicans [14, 151 , particularly nonspecific mechanisms such as enhanced efflux of drug involving ATP binding cassettes or major facilitators, responsible for multidrug resistance [ 16-1 81 . Also, more specific mechanisms consisting of changes in the binding site [19] or catalytic site [20] on the azole target, amplification or increasing transcription of the P-45ODM gene [16, 21, 221 [14, 27, 281 . These studies relied on the comparison of two clinical isolates obtained from a unique patient in which the microorganism had become resistant during treatment with fluconazole. The resistance to fluconazole -which was associated with resistance to ketoconazole and itraconazole -seemed to be due to a failure of intracellular accumulation of drug related to enhanced efflux [24-281 and associated with an increase in sterol biosynthesis [27] . Moreover, RFLP analysis of the genomic DNA of the two isolates before and after treatment showed that they were not related, suggesting selection by the drug of a resistant strain within a double population of yeasts [24] .
The present study, performed with 10 strains cloned by limiting dilution and obtained from unrelated patients, clearly indicates that resistance to azoles for C. glabrata may be acquired by mutation. Antifungal susceptibility testing performed on Casitone agar revealed the presence of large resistant colonies randomly distributed within the inhibition zones for all the azoles tested except tioconazole. The susceptibility pattern of these colonies to polyenes and azoles (determined by the same method) was constant, regardless of the antifungal agent allowing selection. Moreover, colonies selected on the basis of resistance to fluconazole remained resistant to the drug after multiple subcultures in the absence of the antifungal agent, demonstrating stability of the phenotype.
Results obtained on Casitone agar for the fluconazoleresistant mutants were confirmed with Shadomy's modified medium and a synthetic medium, and by determination of fluconazole MICs by the Etest procedure, a method which has been shown to give good agreement with the macro-broth reference dilution method [29-3 11. Fluconazole MICs ranged from 24 to 64 mg/L for the parent strains, consistent with previous reports indicating that this yeast species is relatively resistant to fluconazole [32, 331. For most clinical isolates classified as intermediate or resistant, resistant colonies were detected within the inhibition zones only after incubation for 48 h. Therefore, a comparative study of the growth of the fluconazole-resistant mutants and their parent strains was performed which revealed the respiratory deficiency of the mutants. RFLP analysis of their mtDNA confirmed the mitochondria1 origin of this respiratory deficiency. Six of the mutants exhibited a complete loss of the mtDNA, analogous to rho' 'petite' mutants of S. cerevisiae, whereas four other mutants showed partial deletions of the mtDNA comparable to 'petite' rho-of S. cerevisiae [34] . In addition, the induction of the complete loss of mtDNA by ethidium bromide treatment of a respiratory competent strain suggested that this resistance was a consequence of the respiratory deficiency. It is now well established that the synthesis of P-450DM is stimulated under anaerobic conditions or by the presence of a high concentration of glucose (Crabtree effect) [35] . Similarly, in C. albicans, anaerobic conditions inhibit the antifungal activity of ketoconazole [36] . Therefore, it can be speculated that the absence of respiration imposed by culture conditions (anaerobic conditions, catabolic repression, respiratory inhibitors) or by spontaneous or induced mutations, may stimulate the biosynthesis of P-450DM, leading to the resistance of the yeast to azole derivatives.
The results of the present study confirm and extend previous reports of the high incidence of fluconazole resistance on C. glabrata. The clinical failure of fluconazole therapy in C. glabrata infections has been related to the lower susceptibility of this yeast species to azole derivatives [l], but another hypothesis would be the selection in vivo of mutants resistant to the drug. The clinical relevance of the resistance mechanism identified here remains to be defined. It is possible that in the presence of azoles these mutants present a selective advantage (via the over-expression of P450-DM) allowing them to develop instead of the parent cells. However, during the course of this study, the recovery of an isolate of C. glabrata presenting with a complete resistance to azoles remained very rare. Therefore, it seems possible that the selection of azole-resistant mtDNA mutants rarely occurs in vivo, or that this mutation leads to a reduced virulence. In C. albicans, alterations of hyphal growth [37] and loss of virulence [3 81 associated with acquired resistance to azoles have been described. Several authors have reported an increased incidence of oro-intestinal colonisation by C. glabrata in bone marrow transplant recipients undergoing prophylactic fluconazole or ketoconazole therapy [39, 401 , without a concomittant increase in disseminated infections. Nevertheless, these mutants which reveal differences in their susceptibility to azoles (tioconazole versus others), provide an interesting model to study the mechanism of the action of azole derivatives.
